UPC_CFI_658/2025

METHOD AND PRODUCT FOR LOCALISED OR SPATIAL DETECTION OF NUCLEIC ACID IN A TISSUE SAMPLE

Prozessuale & UnteranträgeKostenfestsetzungenDusseldorf LDGenericWritten Phase

Übersicht Entscheidungen Dokumente Zeitverlauf

Parteien

Kläger

10x Genomics, Inc.

Beklagte

Curio Bioscience Inc.

Richter

Ronny Thomas
Berenice Thom
Andras Kupecz
Martin Schmidt

Patente

EP2697391

CPC-Codes: C12Q1/6827, C12Q1/6841, C12Q1/6837, C12Q1/6853, G01N1/30, G16B30/00, C12Q1/6816, C12N15/11, G16B50/20, C12Q1/6844, C12Q1/6876, G16B50/30…

Sektor: Biotechnology

Ausgang

Nur Kosten

Eingereicht: 16. Juli 2025

Erste Entscheidung: 2. Feb. 2026

Sprache: English

The Düsseldorf Local Division issued a costs decision in the 10x Genomics v Curio Bioscience proceedings (EP 2 697 391), establishing that costs of PI proceedings and main proceedings are capped separately, that mixing of costs between proceedings is inadmissible, and that in partial success the ceiling is reduced proportionally.

Im UPC-Register öffnen